medigraphic.com
SPANISH

Medicina Interna de México

Colegio de Medicina Interna de México.
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2025, Number 07

<< Back

Med Int Mex 2025; 41 (07)

Fictional herbalism: An international problem

Del Carpio OL
Full text How to cite this article

Language: Spanish
References: 24
Page: 446-450
PDF size: 303.42 Kb.


Key words:

Herbal medicine, Cushing’s syndrome, Public health.

ABSTRACT

Nowadays fictitious herbal medicine is considered a global public health problem. North American colleagues have become involved following alerts issued by the FDA. The southern border has been identified as the most affected. The main harmful agent identified has been ArthriKing, although there are currently a large number of harmful supplements.


REFERENCES

  1. Del Carpio-Orantes L, Barrat-Hernández AQ, Salas-GonzálezA. Síndrome de Cushing iatrógeno por suplementos herbolariosfalaces. El caso de Ortiga Ajo Rey y Artri King. MedInt Méx 2021; 37 (4): 599-602. https://doi.org/10.24245/mim.v40i3.8102

  2. Del Carpio Orantes L. Complementos “herbolarios” expandiéndosemaliciosamente de México para el mundo.Artriking y compañíal. Rev Med Inst Mex Seguro Soc.2023; 61 (1): 6-7.

  3. Wei KS, Hurtado CR, Angell TE. Response to letter to the editorfrom Luis Del Carpio-Orantes: [Impact of surreptitiousglucocorticoids in over-the-counter arthritis supplements.J Endocr Soc 2025; bvaf045. https://doi.org/10.1210/jendso/bvaf045

  4. Culler M, Mayfield CK, Aron A, et al. Endocrinologicabnormalities observed among total joint arthroplastypatients using “artri king” and related over-the-countersupplements: a cautionary tale from a safety net hospital.J Clin Med 2024; 13 (23): 7240. https://doi.org/10.3390/jcm13237240

  5. Wei KS, De La Torre MO, Flores A, et al. Characterizing thephysiological side-effects of over-the-counter arthritissupplements. J Endocr Soc 2024; 8 (Suppl 1): bvae163.136.https://doi.org/10.1210/jendso/bvae163.136

  6. Del Carpio-Orantes L, Aguilar-Silva A, Munguía-SerenoÁE, et al. Herbal supplements cause Cushing’s syndrome.J Endocr Soc 2024; 8 (Suppl 1): bvae163.199. https://doi.org/10.1210/jendso/bvae163.199

  7. Del Carpio-Orantes L, Salas-González A, Mejía-Ramos SG,et al. Síndrome de Cushing iatrógeno por complementosherbolarios. Med Int Méx 2024; 40 (3): 238-241. https://doi.org/10.24245/mim.v40i3.8102

  8. Berg EA, Dao L, Yu R, Hurtado C. Artri King-inducedhypothalamic-pituitary-adrenal axis disruption: A report of3 cases. JCEM Case Rep 2023; 2 (1): luad154. doi:10.1210/jcemcr/luad154

  9. Arcos-Diaz A, Flores-Rivera A, Marin-Alvarado CP, Ramírez-Camacho MA. Reacciones adversas graves por consumo deproductos engaño para tratar dolores articulares. Reportede una serie de 3 casos. ILAPHAR 2023.

  10. LeTran V. Sumethasorn M, Dukewich M, et al. Danger indisguise! A case series of supplement-induced GI bleed.Am J Gastroenterol 2023; 118 (10S): S2100. https://doi.org.10.14309/01.ajg.0000962208.23597

  11. Patel R, Sherf S, Lai NB, Yu R. Exogenous Cushing syndromecaused by a “herbal” supplement. AACE Clin Case Rep 2022;8 (6): 239-242. https://doi.org.10.1016/j.aace.2022.08.001

  12. Qurrat-ul-ain A, Sanna F, Amber L, et al. Artri King as a causeof adrenal insufficiency. J Endocr Soc 2024; 8: bvae163.113.https://doi.org/10.1210/jendso/bvae163.113

  13. Maraqa S, Bushnaq L, Singh R, et al. Severe exogenouscushing syndrome caused by a potent steroid concealedin arthritis supplement. J Endocr Soc 2023; 7(Suppl 1): bvad114.332. https://doi.org/10.1210/jendso/bvad114.332

  14. Morales T, Samarasinghe S. A patient with a bronchialcarcinoid presents with cushingoid symptoms due to apotentially dangerous supplement. J Endocr Soc 2023;7: bvad114.1297. https://doi.org/10.1210/jendso/bvad114.1297

  15. Boncompagni AC, Ruiz E, Rider AC. A case of iatrogenicCushing syndrome and subsequent adrenal insufficiencyfrom a hidden ingredient in the supplement Artri Ajo King.J Am Coll Emerg Physicians Open 2023; 4 (4): e13007.https://doi.org.10.1002/emp2.13007

  16. Saad-Omer SM, Kinaan M, Matos M, Yau H. ExogenousCushing syndrome and hip fracture due to over-the-countersupplement (Artri King). Cureus 2023; 15 (7): e41278.https://doi.org.10.7759/cureus.41278

  17. Dunn C, Amaya J, Green P. A case of iatrogenic cushing'ssyndrome following use of an over-the-counter arthritissupplement. Case Rep Endocrinol 2023; 4769258. https://doi.org.10.1155/2023/4769258

  18. Dani A, Ede K, Price H, Gildenstern V. Cushingoid clinicalfeatures in a pediatric patient taking a natural supplement:Buyer beware. JAAD Case Rep 2023; 41: 68-70. https://doi.org.10.1016/j.jdcr.2023.08.035

  19. Mendiola-Villalobos C, Rodriguez-Guevara I, MaldonadoMorales JA, et al. Exogenous Cushing’s syndrome, hepaticinjury, and acute kidney injury associated with the ingestionof “ArtriKing” supplement: Literature review andcase report. Authorea 2025. https://doi.org.10.22541/au.173684897.72733973/v1

  20. Mikhail N, Kurator K, Martey E, et al. Iatrogenic Cushing’ssyndrome caused by adulteration of a health product withdexamethasone. JSM Clin Case Rep 2022; 10 (2): 1201.

  21. Puebla B. Be suspicious of supplements: A case of exogenouscushing syndrome from hidden ingredient. https://nsuworks.nova.edu/hcard/2024/day1/29/

  22. Méndez M. Advertencia sobre FTX Plus y Fitelín Pro:denuncias masivas por afectar salud en Puebla. https://newsweekespanol.com/2025/02/07/advertencia-sobreftx-plus-y-fitelin-pro-denuncias-masivas-por-afectar-saluden-puebla/

  23. Alhassan E, Cidon M. Beyond the label: What is inside your“natural” supplements? Am J Med 2024; 137 (11): e201-e202. doi:10.1016/j.amjmed.2024.07.024

  24. Xiao EY, Pecha RL, Sargsyan Z. Bacteremia, liver injury,and pneumonitis: Strongyloides unleashed by asupplement. Am J Med 2023; 136 (3): 270-272. https://doi.org.10.1016/j.amjmed.2022.09.033




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Med Int Mex. 2025;41